This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting enzyme inhibition. Its trifluoromethyl group enhances the compound's metabolic stability and binding affinity, making it valuable in the development of potential therapeutic agents. Researchers often explore its applications in designing drugs for treating diseases such as cancer, inflammation, and microbial infections. Additionally, its structural features make it a candidate for studying structure-activity relationships (SAR) in drug discovery programs.